Sohail Muhammad, Guo Wenna, Yang Xin, Li Zhiyong, Li Yanli, Xu Hui, Zhao Feng
School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University) Ministry of Education, Yantai University, Yantai, China.
School of Chemistry and Chemical Engineering, Yantai University, Yantai, China.
Front Pharmacol. 2021 Jul 6;12:665387. doi: 10.3389/fphar.2021.665387. eCollection 2021.
Curcumin is a well-known anticancer natural product with various significant bioactivities that has been well documented, but its widespread use is mainly hindered by insufficient ADME properties such as poor solubility and low metabolic stability. Dimethoxycurcumin (DiMC) is a kind of lipophilic compound derived from curcumin that maintains its anticancer potency and has greatly improved systematic bioavailability. Therefore, DiMC is regarded as a promising plant-derived anticancer agent that deserves to be well developed. Herein, we concentrate on the published work by those from original research groups concerned with the pharmacokinetics, efficacy, and mechanism of DiMC involved in the treatment of various tumors, as well as the nanoformulations for effective drug delivery.
姜黄素是一种著名的具有多种重要生物活性的抗癌天然产物,已有充分的文献记载,但其广泛应用主要受到吸收、分布、代谢和排泄(ADME)特性不足的阻碍,如溶解度差和代谢稳定性低。二甲氧基姜黄素(DiMC)是一种源自姜黄素的亲脂性化合物,它保持了抗癌效力,并大大提高了系统生物利用度。因此,DiMC被认为是一种有前途的植物源抗癌剂,值得深入开发。在此,我们专注于各原始研究团队发表的有关DiMC治疗各种肿瘤的药代动力学、疗效和机制以及有效药物递送纳米制剂的研究工作。